Karam Gagi
Neurology · Lansing, MINPI 1023754033
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations.
Across 83 payments — averaging $40.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$359
- Novartis$353
- AbbVie$298
- UCB, Inc.$280
- SK Life Science, Inc.$197
- Microvention, Inc.$195
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,340100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $359 |
| Novartis | 7 | $353 |
| AbbVie | 11 | $298 |
| UCB, Inc. | 14 | $280 |
| SK Life Science, Inc. | 6 | $197 |
| Microvention, Inc. | 2 | $195 |
| Neuropace, Inc. | 1 | $152 |
| Genentech USA, Inc. | 3 | $152 |
| Imperative Care, Inc | 1 | $128 |
| Stryker | 1 | $126 |
| TG Therapeutics, Inc. | 2 | $122 |
| Eisai Inc. | 5 | $100 |
| Novo Nordisk | 2 | $94 |
| Route 92 Medical, Inc. | 1 | $93 |
| Bristol Myers Squibb | 5 | $84 |
| Cala Health, Inc. | 1 | $80 |
| Neurelis, Inc. | 1 | $78 |
| Penumbra, Inc. | 1 | $67 |
| E.r. Squibb & Sons, L.L.C. | 1 | $51 |
| Argenx US, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Pyros Pharmaceuticals, Inc. | 1 | $28 |
| Catalyst Pharmaceuticals, Inc. | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| AstraZeneca | 1 | $22 |
| ITF Therapeutics LLC | 1 | $20 |
| Biogen | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLITAIRE X$251
- STENT$215
- RNS Neurostimulator Kit$152
- ZOOM 88-T LARGE DISTAL PLATFORM$128
- TREVO$126
- OCREVUS$118
- KESIMPTA$115
- Pipeline$108
- ERIC RETRIEVAL DEVICE$108
- TUBING KIT - STROKE$108
How this compares
$3,340 in reported general payments places this provider in the 65th percentile of 652 neurology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 24 | $1,106 |
| Levetiracetam | 15 | $357 |
| Donepezil Hcl | 26 | $293 |
| Topiramate | 23 | $199 |
| Atorvastatin Calcium | 15 | $107 |
Paid to pharmacies, not to this prescriber.
Other neurology in Lansing
- Ryan SmithLansing$333K
- Aaron EllenbogenFarmington Hills$1.6M
- Matthew HoltzmanWayne$1.4M
- Richard TroschFarmington Hills$1.2M
- Wade CooperAnn Arbor$991K
- Bisena BulicaDetroit$900K
- Julie BurnhamMount Clemens$836K
- Amit MasihOkemos$785K
- Martin BelkinFarmington Hills$712K
- Robert PaceOwosso$693K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.